- Company Overview for PELEUS THERAPEUTICS LIMITED (13076921)
- Filing history for PELEUS THERAPEUTICS LIMITED (13076921)
- People for PELEUS THERAPEUTICS LIMITED (13076921)
- Insolvency for PELEUS THERAPEUTICS LIMITED (13076921)
- More for PELEUS THERAPEUTICS LIMITED (13076921)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
09 Nov 2024 | LIQ13 | Return of final meeting in a members' voluntary winding up | |
11 Jul 2024 | LIQ03 | Liquidators' statement of receipts and payments to 14 May 2024 | |
24 May 2023 | AD01 | Registered office address changed from The Cambridge Partnership the Dorothy Hodgkin Building Babraham Research Campus Cambridge CB22 3FH United Kingdom to Salisbury House Station Road Cambridge CB1 2LA on 24 May 2023 | |
24 May 2023 | LIQ01 | Declaration of solvency | |
24 May 2023 | 600 | Appointment of a voluntary liquidator | |
24 May 2023 | RESOLUTIONS |
Resolutions
|
|
13 Dec 2022 | CS01 | Confirmation statement made on 10 December 2022 with no updates | |
19 Aug 2022 | AA | Accounts for a small company made up to 31 December 2021 | |
10 Dec 2021 | CS01 | Confirmation statement made on 10 December 2021 with updates | |
04 Feb 2021 | AP03 | Appointment of Mr Nicholas Tait as a secretary on 4 January 2021 | |
28 Jan 2021 | PSC02 | Notification of Medicxi Iii Lp as a person with significant control on 28 January 2021 | |
06 Jan 2021 | AP01 | Appointment of Mr Nicholas Alexander Williams as a director on 21 December 2020 | |
06 Jan 2021 | PSC07 | Cessation of Richard Michael Lee as a person with significant control on 21 December 2020 | |
11 Dec 2020 | NEWINC |
Incorporation
Statement of capital on 2020-12-11
|